| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,668 |
2,228 |
$142K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,138 |
984 |
$92K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,090 |
1,753 |
$75K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
803 |
717 |
$47K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,476 |
1,223 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
530 |
460 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,478 |
634 |
$13K |
| 99215 |
Prolong outpt/office vis |
160 |
142 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
809 |
658 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
700 |
621 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
134 |
111 |
$5K |
| 99442 |
|
53 |
35 |
$1K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
39 |
34 |
$1K |
| 99441 |
|
65 |
45 |
$812.43 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
465 |
381 |
$381.84 |
| 99417 |
Prolong home eval add 15m |
24 |
18 |
$377.65 |
| 36415 |
Collection of venous blood by venipuncture |
200 |
162 |
$264.57 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
64 |
56 |
$119.09 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
50 |
39 |
$78.24 |
| 86769 |
|
23 |
20 |
$42.13 |
| 81003 |
|
28 |
24 |
$36.74 |